01 3Belmore Neidrauer LLP
02 2Blake Cassels & Graydon LLP
03 25Gilead Sciences Canada Inc.
01 12398887
02 72416757
03 12452217
04 12470365
05 12537095
06 12566922
07 12577288
08 22678907
09 22720856
10 72845553
11 12847871
12 12872424
13 12893843
14 12950307
15 22990210
01 4BICTEGRAVIR SODIUM | EMTRICITABINE | TENOFOVIR ALAFENAMIDE HEMIFUMARATE
02 5DARUNAVIR ETHANOLATE | COBICISTAT | EMTRICITABINE | TENOFOVIR ALAFENAMIDE HEMIFUMARATE
03 7ELVITEGRAVIR | COBICISTAT | EMTRICITABINE | TENOFOVIR ALAFENAMIDE HEMIFUMARATE
04 6EMTRICITABINE | RILPIVIRINE HYDROCHLORIDE | TENOFOVIR ALAFENAMIDE HEMIFUMARATE
05 6EMTRICITABINE | TENOFOVIR ALAFENAMIDE HEMIFUMARATE
06 2TENOFOVIR ALAFENAMIDE HEMIFUMARATE
01 30TABLET
01 12019-06-23
02 12021-02-26
03 72021-07-20
04 12022-08-09
05 12023-11-20
06 12024-09-03
07 12025-05-19
08 12025-09-02
09 12026-12-29
10 22028-02-22
11 22029-05-01
12 72032-08-15
13 12033-12-19
14 12035-06-19
15 22036-06-29
Patent Expiration Date : 2021-07-20
Date Granted : 2011-02-15
ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, TENOFOVIR ALAFENAMIDE HEMIFUMARATE
Brand Name : GENVOYA
Patent Number : 2416757
Filing Date : 2001-07-20
Strength per Unit : 150 mg / 150 mg / 200 mg / 10 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2021-07-20
Date Granted : 2011-02-15
Patent Expiration Date : 2023-11-20
Date Granted : 2011-05-17
ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, TENOFOVIR ALAFENAMIDE HEMIFUMARATE
Brand Name : GENVOYA
Patent Number : 2470365
Filing Date : 2003-11-20
Strength per Unit : 150 mg / 150 mg / 200 mg / 10 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2023-11-20
Date Granted : 2011-05-17
Patent Expiration Date : 2025-05-19
Date Granted : 2011-01-11
ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, TENOFOVIR ALAFENAMIDE HEMIFUMARATE
Brand Name : GENVOYA
Patent Number : 2566922
Filing Date : 2005-05-19
Strength per Unit : 150 mg / 150 mg / 200 mg / 10 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2025-05-19
Date Granted : 2011-01-11
Patent Expiration Date : 2028-02-22
Date Granted : 2014-06-17
ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, TENOFOVIR ALAFENAMIDE HEMIFUMARATE
Brand Name : GENVOYA
Patent Number : 2678907
Filing Date : 2008-02-22
Strength per Unit : 150 mg / 150 mg / 200 mg / 10 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2028-02-22
Date Granted : 2014-06-17
Patent Expiration Date : 2029-05-01
Date Granted : 2016-02-02
ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, TENOFOVIR ALAFENAMIDE HEMIFUMARATE
Brand Name : GENVOYA
Patent Number : 2720856
Filing Date : 2009-05-01
Strength per Unit : 150 mg / 150 mg / 200 mg / 10 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2029-05-01
Date Granted : 2016-02-02
Patent Expiration Date : 2026-12-29
Date Granted : 2016-07-26
ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, TENOFOVIR ALAFENAMIDE HEMIFUMARATE
Brand Name : GENVOYA
Patent Number : 2847871
Filing Date : 2006-12-29
Strength per Unit : 150 mg / 150 mg / 200 mg / 10 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2026-12-29
Date Granted : 2016-07-26
Patent Expiration Date : 2021-07-20
Date Granted : 2011-02-15
EMTRICITABINE, TENOFOVIR ALAFENAMIDE HEMIFUMARATE
Brand Name : DESCOVY
Patent Number : 2416757
Filing Date : 2001-07-20
Strength per Unit : 200 mg / 10 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2021-07-20
Date Granted : 2011-02-15
Patent Expiration Date : 2021-07-20
Date Granted : 2011-02-15
EMTRICITABINE, TENOFOVIR ALAFENAMIDE HEMIFUMARATE
Brand Name : DESCOVY
Patent Number : 2416757
Filing Date : 2001-07-20
Strength per Unit : 200 mg / 25 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2021-07-20
Date Granted : 2011-02-15
Patent Expiration Date : 2032-08-15
Date Granted : 2019-05-28
ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, TENOFOVIR ALAFENAMIDE HEMIFUMARATE
Brand Name : GENVOYA
Patent Number : 2845553
Filing Date : 2012-08-15
Strength per Unit : 150 mg / 150 mg / 200 mg / 10 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2032-08-15
Date Granted : 2019-05-28
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2032-08-15
Date Granted : 2019-05-28
EMTRICITABINE, TENOFOVIR ALAFENAMIDE HEMIFUMARATE
Brand Name : DESCOVY
Patent Number : 2845553
Filing Date : 2012-08-15
Strength per Unit : 200 mg / 10 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2032-08-15
Date Granted : 2019-05-28
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
